Efficacy of Roflumilast in Bronchiectasis Patients with Frequent Exacerbations: A Double-Blinded, Randomized, Placebo-Controlled Pilot Clinical Trial
Siwasak Juthong, Pattaraporn Panyarath
Tuberc Respir Dis. 2022;85(1):67-73.   Published online 2021 Aug 3     DOI: https://doi.org/10.4046/trd.2021.0051
Citations to this article as recorded by Crossref logo
The role of precision medicine in bronchiectasis: emerging data and clinical implications
Grace Oscullo, David de la Rosa, Marta Garcia Clemente, Rosa Giron, Rafael Golpe, Luis Máiz, Miguel Angel Martinez-Garcia
Expert Review of Respiratory Medicine.2023; 17(4): 279.     CrossRef
Exacerbation Prevention and Management of Bronchiectasis
Joon Young Choi
Tuberculosis and Respiratory Diseases.2023; 86(3): 183.     CrossRef
Miguel Barbosa, James D. Chalmers
La Presse Médicale.2023; 52(3): 104174.     CrossRef
Can Phosphodiesterase 4 Inhibitor Therapy Be Used in Respiratory Diseases Other Than Chronic Obstructive Pulmonary Disease?
Mastiyage R Goonathilake, Sara Waqar, Sheeba George, Wilford Jean-Baptiste, Amina Yusuf Ali, Bithaiah Inyang, Feeba Sam Koshy, Kitty George, Prakar Poudel, Roopa Chalasani, Lubna Mohammed
Cureus.2022;[Epub]     CrossRef